---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-059963"
form_type: "8-K"
ticker: "RNAZ"
cik: "0001829635"
company_name: "Transcode Therapeutics, Inc."
filed_at: "2024-05-10T23:59:59+00:00"
generated_at: "2026-06-02T04:08:13.499156+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# TransCode receives Nasdaq delisting notice for minimum bid price and equity non-compliance; intends to appeal

## Summary
- Received delisting notice on May 7, 2024 for failing to regain compliance with $1.00 minimum bid price rule by May 6 deadline.
- Not eligible for second 180-day compliance period due to failure to meet $5M minimum stockholders' equity requirement.
- Company will request a hearing before Nasdaq Hearings Panel by May 14, 2024; hearing stays delisting pending outcome.
- No assurance of regaining compliance; stock remains listed at least through the hearing process.

## SEC filing metadata
- accession: 0001104659-24-059963
- form_type: 8-K
- ticker: RNAZ
- cik: 0001829635
- company_name: Transcode Therapeutics, Inc.
- filed_at: 2024-05-10T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1829635/000110465924059963/0001104659-24-059963-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1829635/000110465924059963/tm2414135d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-059963
- JSON: https://secwatch.observer/filing/0001104659-24-059963.json
- Plain text: https://secwatch.observer/filing/0001104659-24-059963.txt

## Key facts
- Listing & Compliance Notices
  Transcode Therapeutics, Inc. received a nasdaq delisting notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A), 5505(b)(1), 5505(b)(2), 5505(b)(3)).
  - Exchange: nasdaq
  - Notice: delisting notice
  - Deficiency: minimum bid price
  - Rules: 5550(a)(2), 5810(c)(3)(A), 5505(b)(1), 5505(b)(2), 5505(b)(3)
  source text: May 7, 2024, (the “Notice”). The Notice was received from the Listing Qualifications Department (the “Staff”) of the Nasdaq Stock Market (“Nasdaq”) informing the Company that the Staff had determined that the Company has not regained compliance with the Nasdaq Listing Rule 5550(a)(2) (the "Minimum Bid Price Rule") and therefore the Company's common stock would be delisted from The Nasdaq Capital Market unless the Company appeals the Staff's delisting determination by requesting a hearing before the Panel. The Company's request for a hearing will stay any further delisting action by the Staff p
  evidence_url: https://www.sec.gov/Archives/edgar/data/1829635/000110465924059963/0001104659-24-059963-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.